Matthew Mackay, MD
Sports Medicine · Overland Park, KSNPI 1790213783
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $22,677 with a category attached, or 88.2%. Arthrex accounts for 93.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $20,125 and has fallen 97.5% since, to $504 in 2025.
Across 70 payments — averaging $323.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$21K
- Stryker$990
- Ferring Pharmaceuticals Inc.$125
- Miach Orthopaedics, Inc.$109
- Titan Surgical Group, LLC$48
- Skeletal Dynamics Inc$30
- plus $165 from 9 others
What the payments were for
- Grants$20,00088%
- Travel & lodging$9804%
- Food & beverage$1,6967%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 22 | $21,209 |
| Stryker | 28 | $990 |
| Ferring Pharmaceuticals Inc. | 7 | $125 |
| Miach Orthopaedics, Inc. | 1 | $109 |
| Titan Surgical Group, LLC | 2 | $48 |
| Skeletal Dynamics Inc | 1 | $30 |
| Radius Health, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Vericel Corporation | 1 | $19 |
| Vertex | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Encore Medical, LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,677 in reported general payments places this provider in the 80th percentile of 56 sports medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $215 |
| Ondansetron OdtOndansetron | 17 | $100 |
| Meloxicam | 31 | $71 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Overland Park
- Michael KhadaviOverland Park$278K
- Brandon BarndsOverland Park$44K
- Aakash ShahOverland Park$19K
- Michael McCabeOverland Park$6K
- Gregory van Den BergheOverland Park$5K
- Leslie MichaudOverland Park$2K
- Brittany MooreOverland Park$416
- Ethan JaegerOverland Park$312
- Lori Boyajian-OneillOverland Park$81
- Kirk McCulloughLeawood$649K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.